CXCR4 Promotes Neuroblastoma Growth and Therapeutic Resistance through miR-15a/16-1-Mediated ERK and BCL2/Cyclin D1 Pathways
Klein, Shiri, Abraham, Michal, Bulvik, Baruch, Dery, Elia, Weiss, Ido D, Barashi, Neta, Abramovitch, Rinat, Wald, Hanna, Harel, Yaniv, Olam, Devorah, Weiss, Lola, Beider, Katia, Eizenberg, Orly, Wald, Ori, Galun, Eithan, Pereg, Yaron, Peled, Amnon
Published in Cancer research (Chicago, Ill.) (15.03.2018)
Published in Cancer research (Chicago, Ill.) (15.03.2018)
Get full text
Journal Article
Single Dose of the CXCR4 Antagonist BL-8040 Induces Rapid Mobilization for the Collection of Human CD34 + Cells in Healthy Volunteers
Abraham, Michal, Pereg, Yaron, Bulvik, Baruch, Klein, Shiri, Mishalian, Inbal, Wald, Hana, Eizenberg, Orly, Beider, Katia, Nagler, Arnon, Golan, Rottem, Vainstein, Abi, Aharon, Arnon, Galun, Eithan, Caraco, Yoseph, Or, Reuven, Peled, Amnon
Published in Clinical cancer research (15.11.2017)
Published in Clinical cancer research (15.11.2017)
Get full text
Journal Article
In vitro and in vivo therapeutic efficacy of CXCR4 antagonist BKT140 against human non–small cell lung cancer
Fahham, Duha, MSc, Weiss, Ido D., PhD, Abraham, Michal, PhD, Beider, Katia, PhD, Hanna, Wald, Shlomai, Zippora, MSc, Eizenberg, Orly, PhD, Zamir, Gideon, MD, Izhar, Uzi, MD, Shapira, Oz M., MD, Peled, Amnon, PhD, Wald, Ori, MD, PhD
Published in The Journal of thoracic and cardiovascular surgery (01.11.2012)
Published in The Journal of thoracic and cardiovascular surgery (01.11.2012)
Get full text
Journal Article
Promiscuous Chemokine Antagonist (BKT130) Suppresses Laser-Induced Choroidal Neovascularization by Inhibition of Monocyte Recruitment
Chowers, Itay, Eizenberg, Orly, Grunin, Michelle, Rinsky, Batya, Tiosano, Liran, Abraham, Michal, Hagbi-Levi, Shira, Peled, Amnon
Published in Journal of Immunology Research (2019)
Published in Journal of Immunology Research (2019)
Get full text
Journal Article
Development of Novel Promiscuous Anti-Chemokine Peptibodies for Treating Autoimmunity and Inflammation
Abraham, Michal, Wald, Hanna, Vaizel-Ohayon, Dalit, Grabovsky, Valentin, Oren, Zohar, Karni, Arnon, Weiss, Lola, Galun, Eithan, Peled, Amnon, Eizenberg, Orly
Published in Frontiers in immunology (23.11.2017)
Published in Frontiers in immunology (23.11.2017)
Get full text
Journal Article
Expression of GTP-dependent and GTP-independent Tissue-type Transglutaminase in Cytokine-treated Rat Brain Astrocytes
Monsonego, Alon, Shani, Yael, Friedmann, Igor, Paas, Yoav, Eizenberg, Orly, Schwartz, Michal
Published in The Journal of biological chemistry (07.02.1997)
Published in The Journal of biological chemistry (07.02.1997)
Get full text
Journal Article
The High Affinity CXCR4 Inhibitor, BL-8040, Impairs the Infiltration, Migration, Viability, and Differentiation of Regulatory T Cells
Abraham, Michal, Mishalian, Inbal, Vainstein, Abi, Shemesh-Darvish, Liron, Sorani, Ella, Eizenberg, Orly, Peled, Amnon
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
The High-Affinity CXCR4 Antagonist BKT140 Is Safe and Induces a Robust Mobilization of Human CD34+ Cells in Patients with Multiple Myeloma
PELED, Amnon, ABRAHAM, Michal, AVIEL, Sigal, GALUN, Eithan, SHAW, Howard Laurence, EIZENBERG, Orly, HARDAN, Izhar, SHIMONI, Avichai, NAGLER, Arnon, AVIVI, Irit, ROWE, Jacob M, BEIDER, Katia, WALD, Hanna, TIOMKIN, Lena, RIBAKOVSKY, Lena, RIBACK, Yossi, RAMATI, Yaron
Published in Clinical cancer research (15.01.2014)
Published in Clinical cancer research (15.01.2014)
Get full text
Journal Article
Combination of imatinib with CXCR4 antagonist BKT140 overcomes the protective effect of stroma and targets CML in vitro and in vivo
Beider, Katia, Darash-Yahana, Merav, Blaier, Orly, Koren-Michowitz, Maya, Abraham, Michal, Wald, Hanna, Wald, Ori, Galun, Eithan, Eizenberg, Orly, Peled, Amnon, Nagler, Arnon
Published in Molecular cancer therapeutics (01.05.2014)
Published in Molecular cancer therapeutics (01.05.2014)
Get full text
Journal Article
Targeting the CD20 and CXCR4 Pathways in Non-Hodgkin Lymphoma with Rituximab and High-Affinity CXCR4 Antagonist BKT140
BEIDER, Katia, RIBAKOVSKY, Elena, NAGLER, Arnon, ABRAHAM, Michal, WALD, Hanna, WEISS, Lola, ROSENBERG, Evgenia, GALUN, Eithan, AVIGDOR, Abraham, EIZENBERG, Orly, PELED, Amnon
Published in Clinical cancer research (01.07.2013)
Published in Clinical cancer research (01.07.2013)
Get full text
Journal Article
Promiscuous Chemokine Antagonist
Hagbi-Levi, Shira, Grunin, Michelle, Rinsky, Batya, Eizenberg, Orly, Abraham, Michal, Tiosano, Liran, Chowers, Itay, Peled, Amnon
Published in Journal of Immunology Research (31.08.2019)
Get full text
Published in Journal of Immunology Research (31.08.2019)
Journal Article
CXCR4 antagonist 4F-benzoyl-TN14003 inhibits leukemia and multiple myeloma tumor growth
Beider, Katia, Begin, Michal, Abraham, Michal, Wald, Hanna, Weiss, Ido D, Wald, Ori, Pikarsky, Eli, Zeira, Evelyne, Eizenberg, Orly, Galun, Eithan, Hardan, Izhar, Engelhard, Dan, Nagler, Arnon, Peled, Amnon
Published in Experimental hematology (01.03.2011)
Published in Experimental hematology (01.03.2011)
Get full text
Journal Article
Effect of BL-8040, high-affinity CXCR4 antagonist, on T-cell infiltration, tumor growth, and synergy with immunomodulatory agents
Abraham, Michal, Mishalian, Inbal, Harel, Yaniv, Klein, Shiri, Pereg, Yaron, Oberkovitz, Galia, Wald, Hanna, Eizenberg, Orly, Bulvik, Baruch, Vainstein Haras, Abi, Aharon, Arnon, Peled, Amnon
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
The CXCR4 Antagonist BL-8040 Induces a Robust Mobilization of CD34+CD38−CD45RA−CD90+ CD49f+ HSCs with Long-Term and Secondary Myeloid and Lymphoid Repopulating Activity
Abraham, Michal, Oberkovitz, Galia, Bulvik, Baruch, Shiri, Klein, Wald, Hanna, Eizenberg, Orly, Beider, Katia, Nagler, Arnon, Vainstein, Abi, Benami, Eyal, Golan, Rotem, Galun, Eithan, Caraco, Yoseph, Or, Reuven, Peled, Amnon
Published in Blood (08.12.2017)
Published in Blood (08.12.2017)
Get full text
Journal Article
Sequential administration of the high affinity CXCR4 antagonist BKT140 promotes megakaryopoiesis and platelet production
Abraham, Michal, Weiss, Ido D., Wald, Hanna, Wald, Ori, Nagler, Arnon, Beider, Katia, Eizenberg, Orly, Peled, Amnon
Published in British journal of haematology (01.10.2013)
Published in British journal of haematology (01.10.2013)
Get full text
Journal Article
The High Affinity CXCR4 Inhibitor, BL-8040, Induces Apoptosis of AML Blasts and Their Terminal Differentiation By Blocking AKT/ERK Survival Signals and Downregulating BCL-2, MCL-1 and Cyclin-D1 through Regulation of Mir-15a/16-1 Expression
Abraham, Michal, Klein, Shiri, Bulvik, Baruch, Wald, Hanna, Holam, Dvora, Weiss, Lola, Beider, Katia, Eizenberg, Orly, Wald, Ori, Avigdor, Abraham, Benjamini, Ohad, Galun, Eithan, Nagler, Arnon, Pereg, Yaron, Peled, Amnon
Published in Blood (02.12.2016)
Published in Blood (02.12.2016)
Get full text
Journal Article